Your browser doesn't support javascript.
Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant.
Higdon, Melissa M; Baidya, Anurima; Walter, Karoline K; Patel, Minal K; Issa, Hanane; Espié, Emmanuelle; Feikin, Daniel R; Knoll, Maria Deloria.
  • Higdon MM; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA. Electronic address: mhigdon@jhu.edu.
  • Baidya A; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
  • Walter KK; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
  • Patel MK; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Issa H; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Espié E; Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
  • Feikin DR; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Knoll MD; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
Lancet Infect Dis ; 22(8): 1114-1116, 2022 08.
Article in English | MEDLINE | ID: covidwho-1907933
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article